EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Programmed cell death and metastatic evolution in breast cancer: the role of anoikis, necroptosis, and ferroptosis

Alireza H Shirvani, Shirin Mohammadian, Shaghayegh Jamshidi, Mohammad H Khodabandehloo, Soheila Zangoie, Romisa S Moghadam, Adel Amoozade, Cena Aram, Mona Rahimi, Mohammad Javad Kamali, Ali Alishvandi

Apoptosis · 2026-07 · 31 (7)

DOI: 10.1007/s10495-026-02375-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Apoptosis, online erschienen am 16.06.2026. Verfasst von Alireza H Shirvani und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran. Hauptthemen laut MEDLINE: Ferroptosis, Anoikis, Necroptosis, Breast Neoplasms. Die Arbeit nennt 313 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metastatic breast cancer (MBC) remains the leading cause of breast cancer-related mortality, driven by the ability of disseminated tumor cells to survive a series of intrinsically lethal stresses encountered during systemic progression, including loss of extracellular matrix attachment, oxidative damage, and immune-mediated cytotoxicity. While resistance to apoptosis has long been considered central to tumorigenesis, it is now evident that metastatic competence depends on coordinated modulation of multiple regulated cell death (RCD) pathways, notably anoikis, necroptosis, and ferroptosis. In this review, we synthesize current mechanistic and translational evidence describing how breast cancer cells reprogram these pathways across the metastatic cascade. We first delineate the molecular basis of anoikis and the adaptive mechanisms that enable anchorage-independent survival. We then examine how circulating tumor cells withstand oxidative and inflammatory stress through redox adaptation and modulation of necroptotic signaling. Within distant organ niches, microenvironmental factors-including metabolic constraints, inflammatory cues, and iron availability-govern susceptibility to ferroptosis and necroptosis, thereby influencing dormancy and metastatic outgrowth. We further introduce the concept of cell death plasticity, defined as the dynamic and context-dependent capacity of tumor cells to modulate, switch between, or simultaneously regulate multiple RCD pathways in response to microenvironmental and therapeutic pressures. This adaptive property underlies both metastatic persistence and therapy resistance, while simultaneously generating context-specific vulnerabilities. Finally, we critically evaluate emerging therapeutic strategies and biomarker frameworks aimed at exploiting these vulnerabilities. Despite strong preclinical rationale, clinical translation remains limited, underscoring the need for biomarker-driven and combinatorial approaches. Collectively, understanding the dynamic interplay among RCD pathways provides a conceptual and translational foundation for targeting metastatic and treatment-resistant breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisAnoikisNecroptosisBreast NeoplasmsHumansFemaleAnimalsNeoplasm MetastasisTumor MicroenvironmentSignal Transduction

Stichwörter der Autor:innen

AnoikisBreast cancer metastasisCell death plasticityFerroptosisNecroptosisOrgan tropismRegulated cell death

Autor:innen und Institutionen

  • Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran.
  • Islamic Azad University - Qaemshahr Branch, Mazandaran, Iran.
  • Department of Genetics, Faculty of Biological Sciences, Arak University, Tehran, Iran.
  • Aryan Institute of Science and Technology, Amirkola, Iran.
  • Universal Scientific Education and Research Network (USERN), Tehran, Iran. Cenaaram00@khu.ac.ir.
  • Department of Cell and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran. Cenaaram00@khu.ac.ir.

Zitieren

APA

Shirvani, A. H., Mohammadian, S., Jamshidi, S., Khodabandehloo, M. H., Zangoie, S., Moghadam, R. S., Amoozade, A., Aram, C., Rahimi, M., Kamali, M. J., & Alishvandi, A. (2026). Programmed cell death and metastatic evolution in breast cancer: the role of anoikis, necroptosis, and ferroptosis. Apoptosis, 31(7). https://doi.org/10.1007/s10495-026-02375-2

Vancouver

Shirvani AH, Mohammadian S, Jamshidi S, Khodabandehloo MH, Zangoie S, Moghadam RS, et al. Programmed cell death and metastatic evolution in breast cancer: the role of anoikis, necroptosis, and ferroptosis. Apoptosis. 2026;31(7). doi:10.1007/s10495-026-02375-2

BibTeX
@article{Shirvani2026,
  author = {Shirvani, Alireza H and Mohammadian, Shirin and Jamshidi, Shaghayegh and Khodabandehloo, Mohammad H and Zangoie, Soheila and Moghadam, Romisa S and Amoozade, Adel and Aram, Cena and Rahimi, Mona and Kamali, Mohammad Javad and Alishvandi, Ali},
  title = {Programmed cell death and metastatic evolution in breast cancer: the role of anoikis, necroptosis, and ferroptosis},
  journal = {Apoptosis},
  year = {2026},
  volume = {31},
  number = {7},
  doi = {10.1007/s10495-026-02375-2}
}
Kostenlos starten →